SCHEMBL30689423

SCHEMBL30689423

C=C(Cc1nc(-c2ccc(Oc3cc(NC)ccn3)cc2)no1)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 4/20 0.41
▸ MITF O75030 1/20 0.41
▸ NCOA3 Q9Y6Q9 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ LMNA P02545 3/20 0.41
▸ ATM Q13315 1/20 0.41
▸ ACACB O00763 1/20 0.41
▸ GSTP1 P09211 7/20 0.40
▸ HDAC4 P56524 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ NPC1 O15118 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ FFAR1 O14842 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30689303 0.86 TP53 (0.42) TP53MITFNCOA3MAPTLMNA
SCHEMBL30689370 0.86 TP53 (0.42) TP53MITFNCOA3MAPTLMNA
SCHEMBL30689347 0.82 IP6K1 (0.48) TP53MITFNCOA3LMNAATM
SCHEMBL31528007 0.81 MITF (0.43) TP53MITFNCOA3MAPTLMNA
SCHEMBL30689323 0.81 TP53 (0.42) TP53MITFNCOA3MAPTLMNA
SCHEMBL31527827 0.79 TP53 (0.46) TP53MITFNCOA3MAPTLMNA
SCHEMBL30689438 0.79 LMNA (0.51) TP53MITFNCOA3MAPTLMNA
SCHEMBL31527955 0.78 LMNA (0.46) TP53MITFNCOA3MAPTLMNA
SCHEMBL30689333 0.78 GSTP1 (0.43) TP53MITFNCOA3LMNAATM
SCHEMBL30689383 0.77 TP53 (0.41) TP53MITFNCOA3MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543875-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES Sitryx Therapeutics Limited (GB) 2025-04-30 — — EP disclosed
WO-2023247958-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES SITRYX THERAPEUTICS LIMITED (GB) 2023-12-28 — — WO disclosed
Send feedback